Comparable Immune Alterations and Inflammatory Signatures in ME/CFS and Long COVID

Area of Science:

• Immunology
• Post-viral Syndromes
• Chronic Illness

Background:

• Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a complex illness with debilitating fatigue and multisystemic symptoms.
• Long COVID, a post-viral syndrome from SARS-CoV-2 infection, presents overlapping clinical features with ME/CFS.
• Both conditions involve chronic immune activation, suggesting potential shared immunopathological mechanisms.

Purpose of the Study:

• To compare immune biomarkers in patients with ME/CFS and Long COVID against healthy controls.
• To investigate the immunopathological overlap between ME/CFS and Long COVID.

Main Methods:

• Analysis of lymphocyte subsets and cytokine profiles in 190 participants (65 ME/CFS, 54 Long COVID, 70 healthy controls).
• Assessment of psychological status and its correlation with immune markers.

Main Results:

• Both ME/CFS and Long COVID groups exhibited significantly lower levels of lymphocytes, CD8+ T cells, and NK cells compared to healthy controls.
• Elevated levels of pro-inflammatory cytokines (IL-6, TNF, IL-4, IL-10) were observed in both ME/CFS and Long COVID patients relative to controls.
• No statistically significant differences in the measured immune biomarkers were detected between the ME/CFS and Long COVID groups.

Conclusions:

• ME/CFS and Long COVID demonstrate comparable immune and inflammatory profiles.
• The findings suggest a shared immune dysfunction underlying both conditions, irrespective of the initial trigger.
• Further research into these shared mechanisms could inform therapeutic strategies for both post-viral syndromes.